microRNA 4304 (MIR4304)

microRNA 4304 (MIR4304 or hsa-mir-4304) is annotated as a member of the microRNA family, a class of small non-coding RNAs involved in post-transcriptional gene regulation, typically by binding to complementary sequences in messenger RNAs and leading to their degradation or inhibition of translation. However, there is no recognized peer-reviewed evidence describing MIR4304 as a functional or disease-associated microRNA. It is not established as a therapeutic target, biomarker, or pharmacological receptor, nor are there known safety concerns or interacting drugs. Most published research and functional annotation on microRNAs pertains to either well-characterized examples (such as miR-21, miR-155, miR-430 in zebrafish, etc.) or general microRNA biology. MIR4304 appears to be a bioinformatically predicted or poorly characterized miRNA, with a lack of experimental functional evidence. This makes it scientifically inaccurate to treat MIR4304 as a legitimate therapeutic target or receptor at present. Summary of Key Points: - microRNA 4304 is a predicted human microRNA, not a validated therapeutic target. - No experimentally confirmed biological function, disease role, or clinical biomarker use. - No drugs interact specifically with MIR4304, and no recognized safety concerns. - It is best classified as a non-coding RNA (microRNA), but any further assertions about its biology or clinical relevance are unsupported by current evidence. If you need information on microRNAs generally or on a specific, characterized miRNA, provide that name or accession for a more detailed analysis.

Other names

hsa-mir-4304MIR4304microRNA 4304